| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.70T | 5.92T | 5.75T | 5.67T | 5.45T | 5.31T |
| Gross Profit | 1.97T | 2.51T | 2.43T | 2.41T | 2.46T | 2.38T |
| EBITDA | 1.40T | 1.78T | 1.62T | 1.71T | 1.78T | 1.76T |
| Net Income | 549.55B | 685.68B | 637.87B | 679.11B | 672.49B | 651.50B |
Balance Sheet | ||||||
| Total Assets | 18.38T | 16.88T | 14.15T | 11.92T | 11.08T | 10.54T |
| Cash, Cash Equivalents and Short-Term Investments | 732.66B | 921.17B | 887.21B | 844.97B | 1.12T | 840.08B |
| Total Debt | 5.25T | 4.55T | 2.39T | 1.65T | 1.74T | 1.76T |
| Total Liabilities | 12.93T | 11.23T | 8.35T | 6.25T | 5.57T | 5.28T |
| Stockholders Equity | 4.93T | 5.13T | 5.25T | 5.12T | 4.98T | 4.76T |
Cash Flow | ||||||
| Free Cash Flow | 1.27T | 958.47B | 956.97B | 444.74B | 793.08B | 1.06T |
| Operating Cash Flow | 1.67T | 1.25T | 1.71T | 1.08T | 1.47T | 1.68T |
| Investing Cash Flow | -1.08T | -1.18T | -832.43B | -732.48B | -761.59B | -658.92B |
| Financing Cash Flow | -693.34B | -33.55B | -476.48B | -669.84B | -727.26B | -585.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $32.98B | 26.19 | 10.15% | 3.15% | 5.74% | 7.12% | |
77 Outperform | $18.46B | 16.17 | 15.56% | 6.14% | -5.21% | -7.45% | |
62 Neutral | $82.99B | 14.48 | 17.05% | 2.69% | 1.14% | 83.48% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $36.60B | 7.35 | -8.37% | 3.77% | 19.67% | -278.51% | |
59 Neutral | $64.38B | 23.64 | 13.06% | 2.38% | 4.04% | 85.18% |